首页> 外国专利> Compounds of Condensed pyrrole Derivatives, inhibitors of factor Xa and / or vlla Pharmaceutical composition; factor; Preparation Process; and their use to treat fibrinolysis,The abnormal formation of Blood Clots, Stroke, or myocardial infarction, car Disorders

Compounds of Condensed pyrrole Derivatives, inhibitors of factor Xa and / or vlla Pharmaceutical composition; factor; Preparation Process; and their use to treat fibrinolysis,The abnormal formation of Blood Clots, Stroke, or myocardial infarction, car Disorders

机译:缩合吡咯衍生物的化合物,Xa因子和/或vlla的抑制剂因子;制备过程;及其用于治疗纤维蛋白溶解,血栓,中风或心肌梗塞,车祸的异常形成

摘要

The present invention relates to compounds of the formula I CHEM wherein R0 ; R1 ; R2 ;Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
机译:本发明涉及式I 的化合物,其中R <0>; R <1>; R 2; Q; V,G和M具有权利要求中指示的含义。式I化合物是有价值的药理活性化合物。它们具有很强的抗血栓形成作用,适合于例如心血管疾病如血栓栓塞性疾病或再狭窄的治疗和预防。它们是凝血酶Xa因子(FXa)和/或VIIa因子(FVIIa)的可逆抑制剂,通常可用于存在不希望的Xa因子和/或VIIa因子活性或用于治愈的条件下或旨在预防Xa因子和/或VIIa因子的预防。本发明还涉及式I化合物的制备方法,其用途,特别是作为药物中的活性成分的用途,以及包含它们的药物制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号